Effect of anti-vascular endothelial growth factor on the surgical outcome of neovascular glaucoma: An overview and meta-analysis

BACKGROUND: Bevacizumab is known to be very effective in inhibiting ocular neovascularization in neovascular glaucoma (NVG). The purpose of this study is to evaluate the effect of anti-vascular endothelial growth factor on the surgical outcome of Ahmed glaucoma valve implantation (AGVI) in NVG. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hyung Bin, Lee, Na Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483822/
https://www.ncbi.nlm.nih.gov/pubmed/34596134
http://dx.doi.org/10.1097/MD.0000000000027326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483822/
https://www.ncbi.nlm.nih.gov/pubmed/34596134
http://dx.doi.org/10.1097/MD.0000000000027326

Ejemplares similares